Optimization of the process parameters for the removal of boron from drinking water by electrocoagulation—a clean technology

BACKGROUND: There are a number of articles related to removal of boron by electrocoagulation using aluminium electrodes, but there are fewer articles describing the use of magnesium as the anode material. The main disadvantage of aluminium electrodes is the residual aluminium present in the treated water due to cathodic dissolution, which can create health problems. In the case of magnesium electrodes, there is no such disadvantage. This paper presents the results of studies on the removal of boron using magnesium and stainless steel as anode and cathode, respectively. RESULTS: Results show that a maximum removal efficiency of 86.32% was achieved at a current density of 0.2 A dm^?2 and pH of 7 using magnesium as the anode and stainless steel as the cathode. The adsorption of boron fitted the Langmuir adsorption isotherm, suggesting monolayer coverage of adsorbed molecules. The adsorption process follows second‐order kinetics. Temperature studies showed that adsorption was endothermic and spontaneous in nature. CONCLUSIONS: The magnesium hydroxide generated in the cell remove the boron present in the water and reduced to a permissible level and making it drinkable. The process scale up results was consistent with the results obtained from the laboratory scale, showing the robustness of the process. Copyright © 2010 Society of Chemical Industry     

Hemorheologic effects of vasodilation in essential hypertension

Arterial hypertension is often associated with plasma volume contraction and hemoconcentration, which negatively affect the vascular flow resistance and microcirculation. Since some antihypertensive drugs can affect blood rheology, the purpose of this study was to evaluate whether acute and long-term arterial vasodilation with cadralazine influences rheologic parameters in essential hypertension. Twelve patients with unsatisfactorily controlled essential hypertension were studied. In the acute double-blind phase of the study the patients were allocated to treatment with either cadralazine or placebo. Intraarterial blood pressure, cardiac output (dye dilution), and blood rheology (viscosity, hematocrit) were registered before and after the first dose of cadralazine. Then 9 patients (3 dropouts) were treated with cadralazine and placebo during two four-week crossover periods and continued with cadralazine medication during the eight-week open phase of the study. Blood pressure and blood hemoglobin were followed during long-term treatment. A single oral dose of cadralazine caused vasodilation (total peripheral resistance index decreased from 45 to 33 U x m2, P < 0.05), which was accompanied by hemodilution (hematocrit declined from 46.9% to 42.5%, P < 0.05) and a blood viscosity reduction of more than 10%. Viscosity of 45% suspension of erythrocytes in plasma was also reduced, suggesting a possible modification of the microrheologic factors. The changes in total peripheral resistance correlated negatively with the changes in hematocrit. An antihypertensive effect of cadralazine was still observed during the chronic phase of the study, which was not accompanied by hemodilution. It is concluded that arterial vasodilation with cadralazine reduces flow resistance in the circulatory system in hypertension and has acute rheologic effects that disappear during chronic medication.     

Effects of water quality on mangroves in an urban lake system

This study assessed the extent of anthropogenic stresses on two mangrove species (Sonneratia caseolaris and Cerbera odollam) in a tropical coastal lake system. An anaerobic factor, organic pollution and salt factors were identified as being responsible for the risks to mangroves. A flora risk tolerance index was developed to ascertain the spatial and temporal risk of plants to water pollution. This study revealed the risk to the Cerbera odollam species is high, compared to Sonneratia caseolaris. Further, the flora risk tolerance index is a good index for assessing the risks to the mangrove species.     

Allogeneic bone marrow transplantation for low-grade lymphoma

Advanced low-grade lymphomas are usually incurable with conventional-dose chemotherapy. It is uncertain whether cures are possible with high-dose therapy and bone marrow transplant from a human leukocyte antigen (HLA)-identical sibling. We sought to determine the outcome of HLA-identical sibling bone marrow transplants in advanced low-grade lymphoma in an observational study of 113 patients conducted at 50 centers participating in the International Bone Marrow Transplant Registry (IBMTR). The median patient age was 38 years (range, 15 to 61). Eighty percent had stage IV disease at the time of transplantation. The median number of prior chemotherapy regimens was two (range, 0 to 5). Thirty-eight percent had refractory disease and 29% a Karnofsky performance score (KPS) less than 80%. All patients underwent allogeneic bone marrow transplantation from a HLA-identical sibling donor. The conditioning regimen included total-body irradiation (TBI) in 82% of patients; cyclosporine was used for graft-versus-host disease prophylaxis in 74%. Survival, disease-free survival, recurrence rate, treatment-related mortality, and causes of death were determined. Three-year probabilities of recurrence, survival, and disease-free survival were 16% (95% confidence interval [CI], 9% to 27%), 49% (95% CI, 39% to 60%), and 49% (95% CI, 39% to 59%), respectively. Higher survival was associated with pretransplant KPS >/=90%, chemotherapy-sensitive disease, use of a TBI-containing conditioning regimen, and age less than 40 years. We conclude that high-dose therapy followed by transplantation from a HLA-identical sibling leads to prolonged survival in some patients with advanced low-grade lymphoma. Most mortality is treatment-related, and recurrences are rare.     

Thermal expansion behaviour of barium and strontium zirconium phosphates

Ba_1.5-xSr_xZr₄P₅SiO₂₄ compounds withx = 0, 0.25, 0.5, 0.75, 1.0, 1.25 and 1.5, belonging to the low thermal expansion NZP family were synthesized by the solid state reaction method. The XRD pattern could be completely indexed with respect to space group indicating the ordering of vacancy at the divalent cation octahedral sites. The microstructure and bulk thermal expansion coefficient from room temperature to 800°C of the sintered samples have been studied. All the samples show very low coefficient of thermal expansion (CTE), withx = 0 samples showing negative expansion. A small substitution of strontium in the pure barium compound changes the sign of CTE. Similarly,x = 1.5 sample (pure strontium) shows a positive CTE and a small substitution of barium changes its sign.X = 1.0 and 1.25 samples have almost constant CTE over the entire temperature range. The low thermal expansion of these samples can be attributed to the ordering of the ions in the crystal structure of these materials